Cargando…

Chemotranscriptomic Profiling Defines Drug-Specific Signatures of the Glycopeptide Antibiotics Dalbavancin, Vancomycin and Chlorobiphenyl-Vancomycin in a VanB-Type-Resistant Streptomycete

Dalbavancin, vancomycin and chlorobiphenyl-vancomycin share a high degree of structural similarity and the same primary mode of drug action. All inhibit bacterial cell wall biosynthesis through complexation with intermediates in peptidoglycan biosynthesis mediated via interaction with peptidyl-d-ala...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hesketh, Andy, Bucca, Giselda, Smith, Colin P., Hong, Hee-Jeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947799/ https://www.ncbi.nlm.nih.gov/pubmed/33717038 http://dx.doi.org/10.3389/fmicb.2021.641756

Ejemplares similares

Evolutionary conservation of motifs within vanA and vanB of vancomycin-resistant enterococci
por: Memili, Aylin, et al.
Publicado: (2022)

735. Vancomycin-Resistant vanB- and vanA/vanB-type Enterococcus faecium Causing Invasive Infections in Adult Patients in Chile
por: Diaz, Lorena, et al.
Publicado: (2023)

Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia
por: Cheah, Agnes Loo Yee, et al.
Publicado: (2014)

Evaluation of GeneXpert vanA/vanB in the early diagnosis of vancomycin-resistant enterococci infection
por: Li, Zhuo-Lei, et al.
Publicado: (2021)

Vibrational Optical Activity Study of Four Antibiotic (Lipo)glycopeptides: Vancomycin, Oritavancin, Dalbavancin, and Teicoplanin
por: Aerts, Roy, et al.
Publicado: (2022)

Genotypically Confirmed Vancomycin-Resistant Staphylococcus aureus With vanB Gene Among Clinical Isolates in Kathmandu
por: Nepal, Niranjan, et al.
Publicado: (2023)

Screening for vancomycin-resistant enterococci with Xpert® vanA/vanB: diagnostic accuracy and impact on infection control decision making
por: Holzknecht, B.J., et al.
Publicado: (2017)

Characterization of a Tigecycline-, Linezolid- and Vancomycin-Resistant Clinical Enteroccoccus faecium Isolate, Carrying vanA and vanB Genes
por: Wardal, Ewa, et al.
Publicado: (2023)

Frequency of VanA, VanB and VanH variants amongst vancomycin-resistant enterococci isolated from patients in central region of Iran
por: Rezvani, Jaafar, et al.
Publicado: (2016)

Fecal carriage of vanB antibiotic resistance gene affects adipose tissue function under vancomycin use
por: Vliex, Lars M. M., et al.
Publicado: (2022)

Evaluation of the iNtRON VRE vanA/vanB Real-Time PCR Assay for Detection of Vancomycin-Resistant Enterococci
por: Huh, Hee Jae, et al.
Publicado: (2015)

Molecular detection of vanA and vanB genes among vancomycin-resistant enterococci in ICU-hospitalized patients in Ahvaz in southwest of Iran
por: Moosavian, Mojtaba, et al.
Publicado: (2018)

Occult Vancomycin-Resistant Enterococcus faecium ST117 Displaying a Highly Mutated vanB(2) Operon
por: Santona, Antonella, et al.
Publicado: (2023)

Evaluation of Quadruple Real-Time PCR Method to Detect Enterococci Carrying Vancomycin-Resistant Genes vanA, vanB, vanM in Rectal Swabs
por: He, Yuanhui, et al.
Publicado: (2020)

Vancomycin-resistant vanB-type Enterococcus faecium isolates expressing varying levels of vancomycin resistance and being highly prevalent among neonatal patients in a single ICU
por: Werner, Guido, et al.
Publicado: (2012)

Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting
por: Xie, Ouli, et al.
Publicado: (2020)

Incidence of genes encoding vanA/vanB vancomycin resistance in rectal swabs of patients with diagnosed cancer, on the day of admission to hospital, in a non-epidemic period
por: Szymankiewicz, Maria, et al.
Publicado: (2020)

VanB-VanC1 Enterococcus gallinarum, Italy
por: Mammina, Caterina, et al.
Publicado: (2005)

Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus.
por: Tenover, F C, et al.
Publicado: (2001)

Near-ubiquitous presence of a vancomycin-resistant Enterococcus faecium ST117/CT71/vanB –clone in the Rhine-Main metropolitan area of Germany
por: Falgenhauer, Linda, et al.
Publicado: (2019)

Comparison of VITEK(®) 2, three different gradient strip tests and broth microdilution for detecting vanB-positive Enterococcus faecium isolates with low vancomycin MICs
por: Klare, Ingo, et al.
Publicado: (2019)

The changing epidemiology of VanB Enterococcus faecium in Poland
por: Sadowy, Ewa, et al.
Publicado: (2018)

1056. Safety and Tolerability of Dalbavancin in Vancomycin Allergic Patients – A Case Series
por: Freeman, Kennedy J, et al.
Publicado: (2021)

1539. Dalbavancin, Vancomycin, and Daptomycin Alone and in Combination with Cefazolin Against Vancomycin Intermediate-Resistant (VISA) and Daptomycin Non-Susceptible (DNS) Staphylococcus aureus
por: Abdul-Mutakabbir, Jacinda, et al.
Publicado: (2019)

Emergence of VanB phenotype-vanA genotype Enterococcus faecium clinical isolate in Bulgaria
por: Strateva, Tanya, et al.
Publicado: (2014)

Treatment with Saccharomyces boulardii and Escherichia coli Nissle is safe and associated with reduced nosocomial transmission of vanB vancomycin-resistant Enterococcus faecium on an early rehabilitation ward in Germany: a retrospective analysis
por: Borgmann, Stefan, et al.
Publicado: (2019)

Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin
por: Cheng, Mu, et al.
Publicado: (2014)

Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA
por: Lai, Chih-Cheng, et al.
Publicado: (2017)

Biosynthesis of Antibacterial Iron-Chelating Tropolones in Aspergillus nidulans as Response to Glycopeptide-Producing Streptomycetes
por: Gerke, Jennifer, et al.
Publicado: (2022)

Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies
por: Dunne, Michael W, et al.
Publicado: (2015)

Detection of both vanA & vanB genes in vanA phenotypes of Enterococci by Taq Man RT-PCR
por: Mirzaei, Bahman, et al.
Publicado: (2015)

Characterisation of the selective binding of antibiotics vancomycin and teicoplanin by the VanS receptor regulating type A vancomycin resistance in the enterococci
por: Hughes, C.S., et al.
Publicado: (2017)

Real-Time PCR Assay for Rapid and Simultaneous Detection of vanA and vanB Genes in Clinical Strains
por: Zerrouki, Hanane, et al.
Publicado: (2021)

Structural and Functional Adaptation of Vancomycin Resistance VanT Serine Racemases
por: Meziane-Cherif, Djalal, et al.
Publicado: (2015)

Vancomycin does not affect the enzymatic activities of purified VanS(A)
por: Upton, Elizabeth C., et al.
Publicado: (2019)

Total Synthesis of [Ψ[C(=NH)NH]Tpg(4)]Vancomycin and its (4-Chlorobiphenyl)methyl Derivative: Impact of Peripheral Modifications on Vancomycin Analogues Redesigned for Dual d-Ala-d-Ala and d-Ala-d-Lac Binding
por: Okano, Akinori, et al.
Publicado: (2014)

Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures
por: Johnsen, P. J., et al.
Publicado: (2011)

The Role of the Staphylococcal VraTSR Regulatory System on Vancomycin Resistance and vanA Operon Expression in Vancomycin-Resistant Staphylococcus aureus
por: Qureshi, Nadia K., et al.
Publicado: (2014)

Synthetic Biology Facilitates Semisynthetic Development of Type V Glycopeptide Antibiotics Targeting Vancomycin-Resistant Enterococcus
por: Koteva, Kalinka, et al.
Publicado: (2023)

Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium
por: Gargvanshi, Shivani, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s4ral756837mr9b9llrh7mibb0